1. Home
  2. INTZ vs CVKD Comparison

INTZ vs CVKD Comparison

Compare INTZ & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$0.76

Market Cap

16.9M

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$5.68

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
CVKD
Founded
1983
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
13.8M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
INTZ
CVKD
Price
$0.76
$5.68
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.75
$13.00
AVG Volume (30 Days)
90.4K
61.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
71.78
23.94
EPS
N/A
N/A
Revenue
$7,015,000.00
N/A
Revenue This Year
$25.34
N/A
Revenue Next Year
$14.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.56
N/A
52 Week Low
$0.73
$4.21
52 Week High
$2.64
$15.99

Technical Indicators

Market Signals
Indicator
INTZ
CVKD
Relative Strength Index (RSI) 40.20 46.18
Support Level N/A $4.91
Resistance Level $1.20 $6.09
Average True Range (ATR) 0.05 0.74
MACD 0.00 0.04
Stochastic Oscillator 11.80 14.91

Price Performance

Historical Comparison
INTZ
CVKD

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.

Share on Social Networks: